Tag: NYHA

Clinical Implications of the New York Heart Association Classification

aledopress

The New York Heart Association (NYHA) classification has served as a fundamental tool for risk stratification of heart failure (HF) and determines clinical trial eligibility and candidacy for drugs and devices. However, its ability to adequately stratify risk is unclear.. Cumulative mortality varied significantly across NYHA classes and HF clinical trials (likelihood ratio, P<0.001). Mortality… Continue reading Clinical Implications of the New York Heart Association Classification